In some countries, this medicine may only be approved for veterinary use.
In the US, Digoxin (digoxin systemic) is a member of the following drug classes: group V antiarrhythmics, inotropic agents and is used to treat Atrial Fibrillation and Heart Failure.
US matches:
- Digoxin
- Digoxin Capsules
- Digoxin Elixir
- Digoxin Immune Fab
- Digoxin Intravenous
- Digoxin Oral Solution
- Digoxin Tablets
UK matches:
- Digoxin Tablets 62.5mcg, 125mcg, 250mcg (Actavis UK Ltd)
- Digoxin Injection BP 500 micrograms/2ml (SPC)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C01AA05
CAS registry number (Chemical Abstracts Service)
0020830-75-5
Chemical Formula
C41-H64-O14
Molecular Weight
780
Therapeutic Category
Cardiac glycoside
Chemical Name
3beta-[2,6-Didesoxy-O-beta-D-ribohexopyranosyl-(1->4)-2,6-didesoxy-O-beta-D-ribohexopyranosyl-(1->4)-2,6-didesoxy-beta-D-ribohexopyranosyloxy]-12beta,14-dihydroxy-5beta,14beta-card-20(22)-enolid
Foreign Names
- Digoxinum (Latin)
- Digoxin (German)
- Digoxine (French)
- Digoxina (Spanish)
Generic Names
- Digossina (OS: DCIT)
- Digoxin (OS: JAN, BAN)
- Digoxine (OS: DCF)
- Digazolan (IS)
- Lanadicor (IS)
- Digoxin (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XV)
- Digoxine (PH: Ph. Eur. 6)
- Digoxinum (PH: Ph. Int. 4, Ph. Eur. 6)
Brand Names
- Agoxin
Aristopharma, Bangladesh - Apo-Digoxin
Apotex, Canada - Cardiacin
Center, Taiwan - Cardiogoxin
Medipharma, Argentina - Digacin
Mibe, Germany - Digibind
GlaxoSmithKline, Australia; IFET, Greece - Digitek
Bertek, United States; UDL, United States - Digobal
Baldacci, Brazil - Digocard-G
Klonal, Argentina - Digohan
Nipro PharmaNipurofama, Japan - Digoregen
R.A.N., Germany - Digosin
Chugai, Japan - Digossina Biologici
Biologici, Italy - Digossina Salf
Salf, Italy - Digoxanova
Chemnova, Peru - Digoxen
Drug International, Bangladesh - Digoxin Anfarm
Anfarm, Greece - Digoxin BioPhausia
BioPhausia, Sweden - Digoxin Dak
Nycomed, Denmark - Digoxin Grindeks
Grindeks, Estonia; Grindeks, Latvia - Digoxin KY
Kyoto Yakuhin, Japan - Digoxin Leciva
Zentiva, Czech Republic - Digoxin Nycomed
Nycomed, Estonia - Digoxin R.A.N.
R.A.N., Germany - Digoxin Richter
Gedeon Richter, Bulgaria - Digoxin SAD
SAD, Denmark - Digoxin Sopharma
Sopharma, Bulgaria - Digoxin Spofa
Spofa, Czech Republic - Digoxin Streuli
Streuli Pharma, Switzerland - Digoxin Teva
Teva, Latvia - Digoxin
Actavis, United Kingdom; Actavis, United States; Baxter, United States; Caraco, United States; Gedeon Richter, Ethiopia; Gedeon Richter, Hungary; Gedeon Richter, Russian Federation; Gedeon Richter, Vietnam; GlaxoSmithKline, India; Hospira, United States; Impax, United States; Novartis, Greece; Novartis, Turkey; Orion, Finland; Pasteur, Chile; Polfa Kutno, Poland; Polfa Warszawa, Georgia; Polfa Warszawa, Lithuania; Polfa Warszawa, Poland; Remevita, Serbia; Roxane, United States; Sandoz, Canada; Sandoz, United States; Stevens, United States; West-Ward, United States; Wyeth, United States; Zentiva, Romania; Zentiva, Slovakia - Digoxin Pediatric (pediatric)
Sandoz, Canada - Digoxina Biol
Biol, Argentina - Digoxina Kern Pharma
Kern, Spain - Digoxina L.CH.
Chile, Chile - Digoxina Lafedar
Lafedar, Argentina - Digoxina Larjan
Veinfar, Argentina - Digoxina Teofarma
Teofarma, Spain - Digoxina
Bestpharma, Chile; Calidad, Venezuela; Farmindustria, Peru; GlaxoSmithKline, Brazil; Hersil, Peru; Labinco, Colombia; Mintlab, Chile; Novartis, Venezuela; Novartis Pharmaceuticals, Peru; OFA, Venezuela; Perugen, Peru; Rider, Chile - Digoxine Nativelle
Adilna, Turkey; Procter & Gamble, Luxembourg; Procter & Gamble, Tunisia; Teofarma, France - Digoxine Sine
Sine Pharm, China - Digoxine
Procter & Gamble, Tunisia - Digoxine (veterinary use)
Kombivet, Netherlands - Digoxin-Sandoz
Cisuba, Sudan; Heko, Tanzania; Lindsay-Chemie, Zimbabwe; Medview, Ghana; Novartis, Switzerland; Novartis, Indonesia; Novartis, Kenya; Novartis, Libya; Novartis, Nigeria - Digoxin-Zori
Teva, Israel - Dilacor
Zdravlje, Bulgaria; Zdravlje, Serbia - Eudigox
Teofarma, Italy - Fargoxin
Fahrenheit, Indonesia - Halfdigoxin
Kyoto Yakuhin, Japan - Hemigoxine Nativelle
Teofarma, France - Lanacordin Pediatrico (pediatric)
Kern, Spain - Lanibos
Bosnalijek, Bosnia & Herzegowina - Lanicor
Infinity, Venezuela; Pliva, Croatia (Hrvatska); Riemser, Argentina; Riemser, Botswana; Riemser, Czech Republic; Riemser, Ecuador; Riemser, Ghana; Riemser, Kenya; Riemser, Luxembourg; Riemser, Malawi; Riemser, Namibia; Riemser, Nigeria; Riemser, Sudan; Riemser, Tanzania; Riemser, Uganda; Riemser, Zambia; Riemser, Zimbabwe; Teofarma, Germany - Lanoxicaps
GlaxoSmithKline, United States - Lanoxin
Glaxo Wellcome, Portugal; GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Bangladesh; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Brazil; GlaxoSmithKline, Cyprus; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Guyana; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Israel; GlaxoSmithKline, India; GlaxoSmithKline, Iran; GlaxoSmithKline, Iceland; GlaxoSmithKline, Italy; GlaxoSmithKline, Jordan; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Lebanon; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Malta; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Philippines; GlaxoSmithKline, Qatar; GlaxoSmithKline, Romania; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Syria; GlaxoSmithKline, Thailand; GlaxoSmithKline, United States; GlaxoSmithKline, Yemen; GlaxoSmithKline, South Africa; IFET, Greece; Pharmascience, Canada; Roemmers, Argentina; Sigma, Australia; Sigma, Hong Kong; Wellcome, Ireland - Lanoxin (veterinary use)
GlaxoSmithKline, United Kingdom - Lenoxin
GlaxoSmithKline, Germany - PMS-Digoxin
Pharmascience, Canada - Purgoxin
Aspen Pharmacare, South Africa - Sigmaxin
Fawns & McAllan, Australia - Vidaxil
Victory, Mexico
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment